Patent · US Active

Dosing regimens for treatment of fungal infections

US11712459B2 · kind B2 · utility

0Cited by
27References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2017
Grant dateAug 1, 2023
Priority date—
Expiry dateMar 15, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/56961
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure features pharmaceutical compositions, methods, and kits featuring dosing regimens and CD101, or a pharmaceutical acceptable salt or neutral form thereof (e.g., CD101 acetate).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.